Cyclosporine in the management of severe ulcerative colitis while breast-feeding

Inflammatory Bowel Diseases

Volumn 17, Issue 7, 2011, Pages

  Lahiff, Conor ^a   Moss, Alan C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN;

ADULT; ANAMNESIS; BREAST FEEDING; CASE REPORT; CESAREAN SECTION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; INFANT SERUM; LETTER; MALE; MATERNAL SERUM; NEWBORN; PREGNANCY; PRIORITY JOURNAL; SERUM; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADULT; BREAST FEEDING; COLITIS, ULCERATIVE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PREGNANCY; PREGNANCY COMPLICATIONS; REMISSION INDUCTION;

EID: 79958811016     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21765     Document Type: Letter

References (5)

1. Cheifetz AS, Stern J, Garud S, et al. Cyclosporine is safe and effective in patients with severe ulcerative colitis. J Clin Gastroenterol. 2011; 45: 107-112.
2. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001; 108: 776-789.
3. Moss AC, Peppercorn MA,. Steroid-refractory severe ulcerative colitis: what are the available treatment options? Drugs. 2008; 68: 1157-1167. (Pubitemid 351822109)
4. Zelinkova Z, de Haar C, de Ridder L, et al. High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Aliment Pharmacol Ther. 2011; 33: 1053-1058.
5. Moretti ME, Sgro M, Johnson DW, et al. Cyclosporine excretion into breast milk. Transplantation. 2003; 75: 2144-2146. (Pubitemid 36793308)